Mild Traumatic Brain Injury (TBI), also referred to as “concussion,” is one of the most common neurological injuries worldwide. While traditionally considered transient and self-limiting, research over the past decade has revealed that even mild brain trauma can trigger measurable biochemical, inflammatory, and migraine-related neurobiological changes.

For researchers, this shift has transformed how mild TBI is studied. Instead of relying solely on neuroimaging and symptom reporting, investigators now examine Traumatic Brain Injury samples collected from blood.

Among these, blood plasma and serum have emerged as critical biofluids for detecting biomarkers associated with neuron damage, brain atrophy, glial activation, blood–brain barrier disruption, and systemic inflammation.

At Bay Biosciences, we provide high-quality serum and plasma samples from mild Traumatic Brain Injury patients, which help scientists move beyond symptom-based diagnosis and toward molecular-level understanding

Serum and Plasma Samples from Mild Traumatic Brain Injury Patients in Research

Understanding Mild Traumatic Brain Injury (TBI)

Mild Traumatic Brain Injury or concussion occurs when an external mechanical force disrupts normal brain function.

This disruption may be because of varying factors such as a direct blow to the head, rapid acceleration-deceleration movement, or blast exposure.

Although classified as “mild” based on clinical criteria such as brief loss of consciousness (if any) and normal structural imaging, the biological consequences are not always mild.

Even subtle Traumatic Brain Injury can initiate neuronal stress, axonal strain, metabolic imbalance, and inflammatory signaling that can persist beyond the acute phase.

Common Symptoms of Mild TBI

Symptoms of mild Traumatic Brain Injury can vary widely. They may develop immediately or evolve over hours to days.

Neurological Symptoms

Cognitive Symptoms

  • Memory impairment
  • Difficulty concentrating
  • Slowed processing speed
  • Confusion

Emotional and Behavioral Symptoms

Systemic Symptoms

These symptoms are due to multiple factors such as neuronal dysfunction, neuroinflammation, and temporary disruption of neural networks.

Because many of these symptoms largely overlap with migraine, stress disorders, and psychiatric conditions, objective laboratory evaluation using Serum & Plasma Samples from Traumatic Brain Injury patients has become increasingly important in research settings.

Causes of Mild Traumatic Brain Injury

These are some common causes of mild TBI.

  1. Falls
  2. Sports-Related Impact
  3. Motor Vehicle Accidents
  4. Military Blast Exposure
  5. Workplace or Occupational Trauma

Diagnosis of Mild Traumatic Brain Injury

Diagnosing mild TBI can be clinically challenging and requires thorough assessment.

Clinicians typically diagnose mild traumatic brain injury (mTBI) using a structured clinical evaluation that integrates symptom assessment, neurological examination, and cognitive screening tools.

Because mTBI is a functional brain injury rather than a gross structural lesion, the priority is to monitor symptom evolution and mechanism of injury when making diagnostic decisions.

Healthcare professionals also use standardized tools such as the Glasgow Coma Scale, where a score of 13–15 is significant for the diagnosis of mild TBI when obtained within the first few hours after a head injury.

Moreover, Neurocognitive tests that assess memory, attention, processing speed, and reaction time are also commonly used.

CT scans are sometimes performed to rule out bleeding or structural injury. However, most mild TBI cases show normal imaging findings.

Biomarker-Based Research Diagnostics

Because imaging often appears normal, blood-based biomarkers are incorporated to improve diagnostic precision.

Serum and plasma analyses detect proteins released following neuronal and glial injury.

For example:

  • Glial fibrillary acidic protein (GFAP) reflects astrocytic damage.
  • Ubiquitin C-terminal hydrolase L1 (UCH-L1) indicates neuronal cell body injury.
  • Neurofilament light chain (NfL) signals axonal disruption.
  • Inflammatory cytokines such as IL-6, TNF-α, and IL-1β demonstrate systemic and neuroinflammatory activation.

The U.S. FDA has authorized blood tests measuring GFAP and UCH-L1 to assist clinicians in determining whether CT imaging is necessary in adults with suspected mild TBI.

Treatment/ Management of Mild Traumatic Brain Injury

Management of mild Trauma Brain Injury focuses primarily on supportive care and symptom monitoring.

1. Cognitive and Physical Rest

Short-term rest followed by gradual return to activity is recommended.

2. Symptom-Specific Management

3. Monitoring for Persistent Symptoms

Some patients develop post-concussive syndrome, characterized by prolonged cognitive and emotional symptoms that need to be constantly monitored.

Why Blood-Based TBI Samples Are Important

When the brain experiences trauma, even mild trauma, cellular disruption leads to the release of proteins and inflammatory mediators into circulation.

If the blood–brain barrier becomes transiently permeable, neuronal and glial proteins can enter the bloodstream and become detectable in serum or plasma.

By analyzing these circulating markers, researchers can:

  • Detect subtle neuronal injury
  • Monitor inflammatory activity
  • Stratify patients by injury severity
  • Predict recovery trajectories
  • Evaluate therapeutic response

Blood Plasma and Serum: What’s the Difference?

Blood plasma and serum are distinct components of blood and present different analytical insights.

  • Plasma is the liquid part of blood collected with anticoagulants. It retains clotting factors such as fibrinogen.
  • Serum is obtained after blood clotting and centrifugation; it lacks clotting proteins.

To obtain these fractions, laboratories centrifuge plasma and serum samples under carefully controlled conditions, separating cellular components from the liquid biofluid.

Proper centrifugation is important to minimize hemolysis, prevent cellular contamination, and preserve the stability of delicate neuronal and inflammatory biomarkers used in mild Traumatic Brain Injury research.

Acute vs. Chronic Mild TBI: Longitudinal Sampling

One-time sampling often provides limited insight.

However, longitudinal collection of blood plasma and serum leads to a detailed understanding of biomarker kinetics, recovery patterns, risk of post-concussive syndrome, and potential neurodegenerative sequelae.

This has been demonstrated through several studies that repeatedly measure biomarkers such as GFAP, tau, and NFL over acute and extended time points after mild TBI.

Supporting Your Research With Bay Biosciences

Advancing research on mild traumatic brain injury (mTBI) depends on access to high-quality, well-characterized biospecimens.

At Bay Biosciences, we provide a wide range of ethically sourced biospecimens to support neurological and biomarker discovery studies, including:

Our blood plasma and serum samples are carefully processed to help researchers identify biomarkers, validate diagnostic tools, and better understand the biological mechanisms underlying brain injury.

If you have specific inclusion criteria, require custom processing protocols, or need assistance identifying the right samples for your study, our team is here to help.

Please don’t hesitate to reach out with any questions, concerns, or special requests!